期刊文献+

FoxM1在结直肠癌中的表达及其临床意义 被引量:3

Expression and clinical significance of FoxM1 in colorectal cancer
下载PDF
导出
摘要 目的:探讨FoxM1(fork head box M1)在结直肠癌(CRC)中的表达情况及其临床意义。方法:采用PCR(qRT-PCR)及免疫组化检测80例结直肠癌及对应癌旁组织中FoxM 1的水平,分析FoxM 1表达与临床病理参数及预后的关系。结果:结直肠癌组织中FoxM1的相对表达量为1.326±0.018,高于癌旁结直肠组织的FoxM1水平0.612±0.036(P<0.05)。免疫组化示结直肠癌组织中FoxM 1表达水平(70.0%,56/80)明显高于癌旁结直肠组织(12.5%,10/80)(P<0.05),且其表达水平与肿瘤病理分期、Dukes分级、淋巴结转移、肝脏转移均有关(P<0.05)。FoxM 1表达阴性者的无瘤生存率明显高于表达阳性者,差异有统计学意义(P=0.002)。结论:FoxM1在结直肠癌组织的表达对预测CRC患者无瘤生存期及总生存期有重要意义。 Objective:To investigate the level of expression of FoxM1 (fork head box M1)and its physiological significance in colorectal cancer.Methods:Immunohistochemistry and semi -quantitative RT -PCR were used to an-alyze FoxM1 mRNA and protein expression in 80 cases of colorectal cancer and adjacent normal tissues to study rela-tionship with clinical symptoms and disease prognosis.Results:Semi -quantitative RT -PCR showed average FoxM1 mRNA expression levels were 1.326 ±0.018 and 0.612 ±0.036 in colorectal cancer tissue and adjacent normal tis-sue (P〈0.05).Immunohistochemistry showed the level of FoxM1 protein expression was significantly higher incolorectal cancer tissues (70.0%,56 /80)than in normal tissues (12.5%,10 /80)(P〈0.05).The level of FoxM1 protein expression was not correlated with age,gender and tumor site,but linked with lymph node metastasis,Dukes stage,histological grade and liver metastasis.Individuals with high and low levels of FoxM1 expression showed statisti-cally significant differences in the recurrence -free survival rates (P〈0.05).Conclusion:FoxM1 mRNA and protein are highly expressed in colorectal cancers and may be associated with colorectal cancer development and progression.
出处 《现代肿瘤医学》 CAS 2016年第13期2112-2115,共4页 Journal of Modern Oncology
关键词 结直肠癌 FOXM1 PCR 预后 PCR colorectal cancer PCR prognosis
  • 相关文献

参考文献16

  • 1Chen W,Zheng R,Zhang S,et al.Annual report on status of cancer in China[J].Chin J Cancer Res,2014,26(1):48-58.
  • 2Feng B,Sun J,Ling TL,et al.Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer:Feasibility and technical strategies[J].Surg Endosc,2012,26(12):3669-3675.
  • 3Sun J,Jiang T,Qiu Z,et al.Short-term and medium-term clinical outcomes of laparoscopic-assisted and open surgery for colorectal cancer:A single center retrospective case-control study[J].BMC Gastroenterol,2011,11:85.
  • 4Wu YH,Chiu WT,Young MJ,et al.Solanum incanum extract downregulates aldehyde dehydrogenase 1-mediated stemness and inhibits tumor formation in ovarian cancer cells[J].J Cancer,2015,6(10):1011-1019.
  • 5Mitrofanova A,Aytes A,Zou M,et al.Predicting drug response in human prostate cancer from preclinical analysis of in vivo mouse models[J].Cell Rep,2015,12(12):2060-2071.
  • 6Hu C,Ni Z,Li BS,et al.hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation[J].Gut,2015,9:14.
  • 7Nestal de Moraes G,Delbue D,Silva KL,et al.FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance[J].Cell Signal,2015,27(12):2496-2505.
  • 8李晨龙,谢靖红,蒋传路.FoxM1与胶质瘤的研究进展[J].现代肿瘤医学,2014,22(10):2481-2483. 被引量:4
  • 9Mima K,Nishihara R,Qian ZR,et al.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis[J].Gut,2015,8:26.
  • 10Schetter AJ,Leung SY,Sohn JJ,et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J].JAMA,2008,299(4):425-436.

二级参考文献27

  • 1Myatt SS,Lam EW. The emerging roles of forkhead box (Fox) pro-teins in cancer[ J]. Nat Rev Cancer,2007,7(ll) :847 -859.
  • 2Schuller U,Zhao Q,Godinho SA,et al. Forkhead transcription fac-tor FoxMl regulates mitotic entry and prevents spindle defects incerebellar granule neuron precursors [ J ] . Mol Cell Biol,2007,27(23):8259 -8270.
  • 3Littler DR, Alvarez - Fern如dez M,Stein A,et al. Structure of theFoxMl DNA - recognition domain bound to a promoter sequence[J]. Nucleic Acids Res,2010,38( 13) :4527 -4538.
  • 4Lam AK,Ngan AW,Leung MH,et al. FOXM1 b,which is present atelevated levels in cancer cells,has a greater transforming potentialthan FOXM1 c[J]. Front Oncol,2013,3 :11.
  • 5Fu Z,Malureanu L,Huang J,et al. Plkl - dependent phosphoryla-tion of FoxMl regulates a transcriptional programme required formitotic progression[ J]. Nat Cell Biol,2008,10(9) :1076 -1082.
  • 6Teh MT,Wong ST,Neill GW,et al. FOXM1 is a downstream targetof Glil in basal cell carcinomas [ J ]. Cancer Res, 2002,62 (16):4773 -4780.
  • 7Gartel AL. FoxMl inhibitors as potential anticancer drugs[ J]. Ex-pert Opin Ther Targets,2008,12(6) :663 -665.
  • 8Yoshida Y,Wang IC,Yoder HM’et al The forkhead box Ml transcrip-tion factor contributes to the development and growth of mouse colorec-tal cancer[ J]. Gastroenterology ,2007 ,132 ( 4 ) :1420 - 1431.
  • 9Li Q,Zhang N,Jia Z,et al. Critical role and regulation of transcrip-tion factor FoxMl in human gastric cancer angiogenesis and pro-gression [J]. Cancer Res,2009,69(8) :3501 -3509.
  • 10Chan DW, Yu SYM,Chiu PM,et al. Over - expression of FOXM1transcription factor is associated with cervical cancer progressionand pathogenesis [ J]. J Pathol,2008,215(3) :245 - 252.

共引文献3

同被引文献25

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部